US Bancorp DE Sells 1,380 Shares of Option Care Health, Inc. (NASDAQ:OPCH)

US Bancorp DE lessened its holdings in shares of Option Care Health, Inc. (NASDAQ:OPCH) by 14.4% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 8,179 shares of the company’s stock after selling 1,380 shares during the period. US Bancorp DE’s holdings in Option Care Health were worth $256,000 at the end of the most recent quarter.

Several other institutional investors have also modified their holdings of OPCH. Thrivent Financial for Lutherans lifted its stake in Option Care Health by 9.1% in the second quarter. Thrivent Financial for Lutherans now owns 5,459,119 shares of the company’s stock valued at $151,218,000 after buying an additional 455,310 shares in the last quarter. Westfield Capital Management Co. LP raised its holdings in shares of Option Care Health by 15.4% during the first quarter. Westfield Capital Management Co. LP now owns 5,171,385 shares of the company’s stock worth $173,448,000 after acquiring an additional 688,653 shares during the period. Dimensional Fund Advisors LP lifted its position in Option Care Health by 6.5% in the 2nd quarter. Dimensional Fund Advisors LP now owns 3,605,271 shares of the company’s stock valued at $99,870,000 after acquiring an additional 218,844 shares in the last quarter. Magnetar Financial LLC boosted its stake in Option Care Health by 124.8% in the 2nd quarter. Magnetar Financial LLC now owns 2,481,935 shares of the company’s stock worth $68,750,000 after purchasing an additional 1,377,929 shares during the period. Finally, Massachusetts Financial Services Co. MA acquired a new position in Option Care Health in the 2nd quarter worth $68,003,000. Institutional investors own 98.05% of the company’s stock.

Analyst Ratings Changes

A number of analysts have recently commented on the company. Barrington Research cut their price target on Option Care Health from $40.00 to $32.00 and set an “outperform” rating on the stock in a report on Thursday, October 31st. JMP Securities boosted their target price on Option Care Health from $36.00 to $37.00 and gave the company a “market outperform” rating in a research note on Monday, September 30th. Truist Financial reduced their price target on Option Care Health from $41.00 to $34.00 and set a “buy” rating for the company in a research report on Friday, November 1st. The Goldman Sachs Group downgraded shares of Option Care Health from a “buy” rating to a “neutral” rating and lowered their price objective for the company from $38.00 to $27.00 in a report on Monday, November 4th. Finally, Bank of America cut shares of Option Care Health from a “buy” rating to a “neutral” rating and reduced their target price for the stock from $43.00 to $29.00 in a report on Wednesday, October 30th. Three investment analysts have rated the stock with a hold rating and three have given a buy rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $30.83.

Insider Buying and Selling

In other news, Director Harry M. Jansen Kraemer, Jr. purchased 43,000 shares of the business’s stock in a transaction on Friday, November 8th. The stock was purchased at an average price of $22.54 per share, for a total transaction of $969,220.00. Following the completion of the purchase, the director now directly owns 326,334 shares in the company, valued at $7,355,568.36. The trade was a 0.00 % increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. In other Option Care Health news, Director Harry M. Jansen Kraemer, Jr. acquired 43,000 shares of the business’s stock in a transaction dated Friday, November 8th. The stock was bought at an average cost of $22.54 per share, with a total value of $969,220.00. Following the completion of the transaction, the director now directly owns 326,334 shares in the company, valued at approximately $7,355,568.36. This represents a 0.00 % increase in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, Director Elizabeth Quadros Betten sold 47,531 shares of Option Care Health stock in a transaction that occurred on Wednesday, August 21st. The stock was sold at an average price of $31.09, for a total value of $1,477,738.79. Following the transaction, the director now owns 21,339 shares of the company’s stock, valued at $663,429.51. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.64% of the stock is owned by corporate insiders.

Option Care Health Trading Down 2.9 %

Shares of Option Care Health stock opened at $22.18 on Thursday. The stock has a market cap of $3.77 billion, a P/E ratio of 18.80, a P/E/G ratio of 2.37 and a beta of 1.32. The company has a quick ratio of 1.32, a current ratio of 1.73 and a debt-to-equity ratio of 0.77. Option Care Health, Inc. has a 12-month low of $22.11 and a 12-month high of $34.63. The business’s 50 day moving average is $29.24 and its 200-day moving average is $29.54.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.